A. “Diagnostic Value of the Impairment of Olfaction in Parkinson’s Disease,” by Swaantje Casjens, Angelika Eckert, Dirk Woitalla, Gisa Ellrichmann, Michael Turewicz, Christian Stephan, Martin Eisenacher, Caroline May, Helmut E. Meyer, Thomas Bruning, and Beate Pesch (PLoS ONE 8(5): e64735. doi:10.1371/journal.pone.0064735, XML, HTML, and .pdf format, 7p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0064735
B. “Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study,” by Irina Vasilyeva, Robert G. Biscontri, Murray W. Enns, Colleen J. Metge, and Silvia Alessi-Severini (PLoS ONE 8(5): e64217. doi:10.1371/journal.pone.0064217, XML, HTML, and .pdf format, 7p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0064217
C. “Intravenous Immunglobulin Binds Beta Amyloid and Modifies Its Aggregation, Neurotoxicity and Microglial Phagocytosis In Vitro,” by Susann Cattepoel, Alexander Schaub, Miriam Ender, Annette Gaida, Alain Kropf, Ursula Guggisberg, Marc W. Nolte, Louis Fabri, Paul A. Adlard, David I. Finkelstein, Reinhard Bolli, and Sylvia M. Miescher (PLoS ONE 8(5): e63162. doi:10.1371/journal.pone.0063162, XML, HTML, and .pdf format, 14p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063162
